The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc. | COM | 00289Y107 | 28,718 | 1,684,364 | SH | SOLE | 1,684,364 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 972,631 | 25,819,768 | SH | SOLE | 25,819,768 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 6,117 | 163,900 | SH | SOLE | 163,900 | 0 | 0 | ||
Achaogen, Inc. | COM | 004449104 | 61,996 | 3,886,878 | SH | SOLE | 3,886,878 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 8,336 | 1,856,637 | SH | SOLE | 1,856,637 | 0 | 0 | ||
Acorda Therapeutics, Inc. | COM | 00484M106 | 12,286 | 519,500 | SH | SOLE | 519,500 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 3,655 | 172,630 | SH | SOLE | 172,630 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 819 | 100,000 | SH | SOLE | 600,000 | 0 | 0 | ||
Advanced Accelerator Applications S.A. | SPONSORED ADS | 00790T100 | 151,689 | 2,243,262 | SH | SOLE | 4,486,524 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 5,609 | 1,137,872 | SH | SOLE | 1,137,872 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 14,549 | 299,356 | SH | SOLE | 299,356 | 0 | 0 | ||
Aevi Genomic Medicine, Inc. | COM | 00835P105 | 5,728 | 4,546,426 | SH | SOLE | 4,546,426 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 900 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 8,588 | 128,666 | SH | SOLE | 128,666 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 16,706 | 673,908 | SH | SOLE | 673,908 | 0 | 0 | ||
Akari Therapeutics plc | SPONSORED ADR | 00972G108 | 3,051 | 496,901 | SH | SOLE | 49,690,100 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 4,190 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,200,022 | 8,553,864 | SH | SOLE | 8,553,864 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 7,639 | 150,251 | SH | SOLE | 150,251 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | 79,343 | 22,669,509 | SH | SOLE | 22,669,509 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 3,893 | 111,386 | SH | SOLE | 111,386 | 0 | 0 | ||
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 155,156 | 10,934,154 | SH | SOLE | 10,934,154 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 1,120 | 180,582 | SH | SOLE | 180,582 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 2,261 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Array BioPharma Inc. | COM | 04269X105 | 64,126 | 5,213,528 | SH | SOLE | 5,213,528 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 85,145 | 2,348,840 | SH | SOLE | 2,348,840 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 8,730 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
AveXis, Inc. | COM | 05366U100 | 74,966 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 403,332 | 3,898,431 | SH | SOLE | 50,679,603 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 58,123 | 5,032,313 | SH | SOLE | 5,032,313 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 73,346 | 13,997,172 | SH | SOLE | 13,997,172 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 620 | 210,021 | SH | SOLE | 210,021 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 549,641 | 5,905,673 | SH | SOLE | 5,905,673 | 0 | 0 | ||
BioPharmX Corporation | COM | 09072X101 | 171 | 598,758 | SH | SOLE | 598,758 | 0 | 0 | ||
BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | 4 | 20,084 | SH | SOLE | 20,084 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 33,162 | 241,441 | SH | SOLE | 241,441 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 12,857 | 5,102,153 | SH | SOLE | 5,102,153 | 0 | 0 | ||
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,423 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 26,604 | 9,745,209 | SH | SOLE | 9,745,209 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 364 | 49,064 | SH | SOLE | 49,064 | 0 | 0 | ||
Clementia Pharmaceuticals Inc. | COM ADDED | 185575107 | 4,223 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ContraFect Corporation | COM | 212326102 | 7,940 | 7,153,076 | SH | SOLE | 7,153,076 | 0 | 0 | ||
Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | 98 | 13,253 | SH | SOLE | 13,253 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 24,114 | 2,991,775 | SH | SOLE | 2,991,775 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 233,826 | 5,509,560 | SH | SOLE | 2,754,780 | 0 | 0 | ||
Dimension Therapeutics, Inc. | COM | 25433V105 | 7,511 | 1,251,881 | SH | SOLE | 1,251,881 | 0 | 0 | ||
Dynavax Technologies Corporation | COM NEW | 268158201 | 1,613 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Epizyme, Inc. | COM | 29428V104 | 4,429 | 232,481 | SH | SOLE | 232,481 | 0 | 0 | ||
Exelixis, Inc. | COM | 30161Q104 | 50,447 | 2,082,012 | SH | SOLE | 2,082,012 | 0 | 0 | ||
Five Prime Therapeutics, Inc. | COM | 33830X104 | 787 | 19,247 | SH | SOLE | 19,247 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 13,690 | 2,466,702 | SH | SOLE | 2,466,702 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 599 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 26,444 | 259,894 | SH | SOLE | 259,894 | 0 | 0 | ||
Genomic Health, Inc. | COM | 37244C101 | 442,215 | 13,780,480 | SH | SOLE | 13,780,480 | 0 | 0 | ||
GlycoMimetics, Inc. | COM | 38000Q102 | 7,881 | 563,312 | SH | SOLE | 563,312 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 7,612 | 75,000 | SH | SOLE | 900,000 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | COM | 40637H109 | 27,469 | 1,581,424 | SH | SOLE | 1,581,424 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 45,026 | 2,787,992 | SH | SOLE | 2,787,992 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | 22,984 | 10,306,757 | SH | SOLE | 10,306,757 | 0 | 0 | ||
Ignyta, Inc. | COM | 451731103 | 16,045 | 1,299,199 | SH | SOLE | 1,299,199 | 0 | 0 | ||
Immune Design Corp. | COM | 45252L103 | 1,541 | 148,937 | SH | SOLE | 148,937 | 0 | 0 | ||
ImmunoGen, Inc. | COM | 45253H101 | 20,567 | 2,688,489 | SH | SOLE | 2,688,489 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 3,996,048 | 34,230,323 | SH | SOLE | 34,230,323 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 772 | 580,400 | SH | SOLE | 580,400 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 21,847 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Intellia Therapeutics, Inc. | COM | 45826J105 | 26,394 | 1,062,120 | SH | SOLE | 1,062,120 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 9,613 | 609,166 | SH | SOLE | 609,166 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 68,292 | 7,288,300 | SH | SOLE | 7,288,300 | 0 | 0 | ||
InVivo Therapeutics Holdings Corp. | COM NEW | 46186M209 | 580 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Jounce Therapeutics, Inc. | COM | 481116101 | 1,558 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | COM | 48576U106 | 2,383 | 216,990 | SH | SOLE | 216,990 | 0 | 0 | ||
Krystal Biotech, Inc. | COM ADDED | 501147102 | 1,994 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 5,380 | 154,675 | SH | SOLE | 154,675 | 0 | 0 | ||
Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | 9,992 | 73,386 | SH | SOLE | 73,386 | 0 | 0 | ||
Loxo Oncology, Inc. | COM | 548862101 | 8,849 | 96,062 | SH | SOLE | 96,062 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 6,721 | 363,676 | SH | SOLE | 363,676 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 2,598 | 57,762 | SH | SOLE | 57,762 | 0 | 0 | ||
MediWound Ltd. | ORD SHS | M68830104 | 1,209 | 226,000 | SH | SOLE | 226,000 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 23,049 | 1,160,014 | SH | SOLE | 1,160,014 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 26,549 | 2,269,198 | SH | SOLE | 2,269,198 | 0 | 0 | ||
Molecular Templates, Inc. | COM ADDED | 608550109 | 505 | 72,412 | SH | SOLE | 72,412 | 0 | 0 | ||
MyoKardia, Inc. | COM | 62857M105 | 15,223 | 355,264 | SH | SOLE | 355,264 | 0 | 0 | ||
Nabriva Therapeutics plc | SHS | G63637105 | 7,684 | 938,235 | SH | SOLE | 938,235 | 0 | 0 | ||
Natera, Inc. | COM | 632307104 | 2,948 | 228,676 | SH | SOLE | 228,676 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 37,790 | 616,682 | SH | SOLE | 616,682 | 0 | 0 | ||
NeuroDerm Ltd. | ORD SHS | M74231107 | 22,238 | 571,667 | SH | SOLE | 571,667 | 0 | 0 | ||
Newlink Genetics Corporation | COM | 651511107 | 10,254 | 1,007,273 | SH | SOLE | 1,007,273 | 0 | 0 | ||
Novavax, Inc. | COM | 670002104 | 2,280 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
Ovid Therapeutics Inc. | COM | 690469101 | 2,857 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | ||
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 23,190 | 3,150,808 | SH | SOLE | 3,150,808 | 0 | 0 | ||
Proteon Therapeutics, Inc. | COM | 74371L109 | 597 | 298,591 | SH | SOLE | 298,591 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 2,598 | 177,952 | SH | SOLE | 177,952 | 0 | 0 | ||
Rigel Pharmaceuticals, Inc. | COM NEW | 766559603 | 6,398 | 2,518,882 | SH | SOLE | 2,518,882 | 0 | 0 | ||
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 980 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
Sage Therapeutics, Inc. | COM | 78667J108 | 25,262 | 405,485 | SH | SOLE | 405,485 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 31,701 | 2,113,376 | SH | SOLE | 2,113,376 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 2,487,928 | 45,725,556 | SH | SOLE | 45,725,556 | 0 | 0 | ||
Selecta Biosciences, Inc. | COM | 816212104 | 5,289 | 289,809 | SH | SOLE | 289,809 | 0 | 0 | ||
Spark Therapeutics, Inc. | COM | 84652J103 | 123,409 | 1,384,130 | SH | SOLE | 1,384,130 | 0 | 0 | ||
Spring Bank Pharmaceuticals, Inc. | COM | 849431101 | 6,284 | 373,144 | SH | SOLE | 373,144 | 0 | 0 | ||
Stemline Therapeutics, Inc. | COM | 85858C107 | 7,032 | 633,497 | SH | SOLE | 633,497 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 1,439 | 741,665 | SH | SOLE | 741,665 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 8,462 | 574,835 | SH | SOLE | 574,835 | 0 | 0 | ||
T2 Biosystems, Inc. | COM | 89853L104 | 420 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Tenax Therapeutics, Inc. | COM | 88032L100 | 126 | 348,374 | SH | SOLE | 348,374 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | COM | 88165N105 | 6,395 | 935,000 | SH | SOLE | 935,000 | 0 | 0 | ||
Tonix Pharmaceuticals Holdings Corp. | COM | 890260409 | 3,190 | 699,500 | SH | SOLE | 699,500 | 0 | 0 | ||
Trevena, Inc. | COM | 89532E109 | 2,423 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
Trillium Therapeutics Inc. | COM NEW | 89620X506 | 2,131 | 413,697 | SH | SOLE | 413,697 | 0 | 0 | ||
Vanda Pharmaceuticals Inc. | COM | 921659108 | 7,588 | 423,884 | SH | SOLE | 423,884 | 0 | 0 | ||
Versartis, Inc. | COM | 92529L102 | 3,521 | 1,437,214 | SH | SOLE | 1,437,214 | 0 | 0 | ||
Voyager Therapeutics, Inc. | COM | 92915B106 | 4,880 | 237,014 | SH | SOLE | 237,014 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 19,988 | 872,072 | SH | SOLE | 872,072 | 0 | 0 | ||
Acorda Therapeutics, Inc. | NOTE 1.75% 6/15/2021 | 00484MAA4 | 31,574 | 35,083,000 | PRN | SOLE | 35,083,000 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | NOTE 2.0% 8/15/2019 | 00767EAB8 | 7,576 | 9,517,000 | PRN | SOLE | 9,517,000 | 0 | 0 | ||
Array BioPharma Inc. | NOTE 3.0% 6/1/2020 | 04269XAA3 | 5,410 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.75% 10/15/2018 | 09061GAE1 | 13,634 | 12,228,000 | PRN | SOLE | 12,228,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 ADDED | 09061GAH4 | 15,193 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
Inotek Pharmaceuticals Corporation | NOTE 5.75% 8/1/2021 | 45780VAB8 | 3,904 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Novavax, Inc. | NOTE 3.75% 2/1/2023 | 670002AB0 | 39,536 | 88,500,000 | PRN | SOLE | 88,500,000 | 0 | 0 | ||
Protalix BioTherapeutics, Inc. | NOTE 4.5% 9/15/2018 | 74365AAB7 | 2,576 | 3,423,000 | PRN | SOLE | 3,423,000 | 0 | 0 |